Enzo Biochem Inc
ENZ
Revenue
7.53M
▼-496.00k▼-6.18%
3 Months ChangeAssets
85.76M
▼-7.71M▼-8.24%
3 Months ChangeLiabilities
29.65M
▲5.21M▲21.34%
3 Months ChangeFree Cash Flow
-13.63M
▼-4.28M▼-45.83%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
Date | Revenue | Cost Of Revenue |
---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
Date | Net Profit/Loss |
---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
Date | Assets | Liabilities |
---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
Date | EPS | EPS (Diluted) |
---|---|---|
Outstanding Shares
Loading...
Date | Outstanding Shares |
---|---|
Recent 8-K/10-Q Filings
2024-10-30
Form 8-K
ID: 0001213900-24-091895
2024-09-24
Form 8-K
ID: 0001213900-24-081479
2024-08-14
Form 8-K
ID: 0001213900-24-069031
2024-08-02
Form 8-K
ID: 0001213900-24-064752
2024-07-25
Form 8-K
ID: 0001013762-24-001207
2024-06-13
Form 10-Q
ID: 0001213900-24-052447
2024-05-24
Form 8-K
ID: 0001213900-24-046692
2024-03-13
Form 8-K
ID: 0001213900-24-022188
2024-03-13
Form 10-Q
ID: 0001213900-24-022179
2024-02-27
Form 8-K
ID: 0001213900-24-017519